Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction
暂无分享,去创建一个
H. Aburatani | Y. Kamatani | K. Matsuda | K. Ozaki | M. Kubo | Y. Momozawa | C. Terao | A. Takahashi | S. Nomura | H. Ieki | Kaoru Ito | H. Akazawa | M. Akiyama | Shinya Oki | Masamichi Ito | Y. Onouchi | K. Miyazawa | I. Komuro | S. Koyama | Y. Koike | Zhaonan Zou | Yoshinori Murakami | Seitaro Nomura | Hiroshi Matsunaga | R. Kurosawa | Masayuki Kubota | Hiroki Yoshida | Koichi Yoshinori Yoichiro Matsuda Murakami Kamatani | K. Ito | M. Kubo | K. Ito | Ryo Kurosawa
[1] M. Maienschein-Cline,et al. Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation , 2021, Stem cell reports.
[2] Ryan L. Collins,et al. Genome-wide enhancer maps link risk variants to disease genes , 2021, Nature.
[3] W. Rottbauer,et al. Spen deficiency interferes with Connexin 43 expression and leads to heart failure in zebrafish. , 2021, Journal of molecular and cellular cardiology.
[4] Michael J. Purcaro,et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes , 2020, Nature.
[5] R. Kettenhofen,et al. Voltage-sensing optical recording: A method of choice for high-throughput assessment of cardiotropic effects. , 2020, Journal of pharmacological and toxicological methods.
[6] Bjarni J. Vilhjálmsson,et al. LDpred2: better, faster, stronger , 2020, bioRxiv.
[7] P. Elliott,et al. Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease. , 2020, JAMA.
[8] C. Robinson-Cohen,et al. Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease. , 2020, JAMA.
[9] Spiros C. Denaxas,et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure , 2020, Nature Communications.
[10] D. Rader,et al. Genetics of height and risk of atrial fibrillation: A Mendelian randomization study , 2019, PLoS medicine.
[11] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[12] M. Memo,et al. Human iPSC modelling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes , 2019, Cardiovascular research.
[13] Alicia R. Martin,et al. Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.
[14] David G. Knowles,et al. Predicting Splicing from Primary Sequence with Deep Learning , 2019, Cell.
[15] Y. Hata,et al. Characterization of a small molecule that promotes cell cycle activation of human induced pluripotent stem cell-derived cardiomyocytes. , 2019, Journal of molecular and cellular cardiology.
[16] Jun Sese,et al. ChIP‐Atlas: a data‐mining suite powered by full integration of public ChIP‐seq data , 2018, EMBO reports.
[17] Tanya M. Teslovich,et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology , 2018, Nature Genetics.
[18] Jay A. Montgomery,et al. Multi-ethnic genome-wide association study for atrial fibrillation , 2018, Nature Genetics.
[19] B. Neale,et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.
[20] Reporting for specific materials, systems and methods , 2018 .
[21] D. Posthuma,et al. Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.
[22] Nicola J. Rinaldi,et al. Genetic effects on gene expression across human tissues , 2017, Nature.
[23] Mary Goldman,et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics , 2016, Nature Communications.
[24] Kathleen F. Kerr,et al. Genetic loci associated with heart rate variability and their effects on cardiac disease risk , 2017, Nature Communications.
[25] Emelia J. Benjamin,et al. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes , 2017, Circulation research.
[26] Y. Kamatani,et al. Identification of six new genetic loci associated with atrial fibrillation in the Japanese population , 2017, Nature Genetics.
[27] Henry J. Lin,et al. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation , 2017, Nature Genetics.
[28] Glenn E. Morris,et al. Novel nesprin-1 mutations associated with dilated cardiomyopathy cause nuclear envelope disruption and defects in myogenesis , 2017, Human molecular genetics.
[29] Y. Kamatani,et al. Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases , 2017, Journal of epidemiology.
[30] Y. Kamatani,et al. Overview of the BioBank Japan Project: Study design and profile , 2017, Journal of epidemiology.
[31] Jun Zhu,et al. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study , 2016, The Lancet.
[32] Alan M. Kwong,et al. Next-generation genotype imputation service and methods , 2016, Nature Genetics.
[33] P. Michela,et al. Role of connexin 43 in cardiovascular diseases. , 2015, European journal of pharmacology.
[34] B. Shields,et al. A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults , 2015, Diabetes Care.
[35] Yenn-Jiang Lin,et al. Inflammation and the pathogenesis of atrial fibrillation , 2015, Nature Reviews Cardiology.
[36] Yasunari Kanda,et al. Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology. , 2014, Journal of molecular and cellular cardiology.
[37] Stanley Nattel,et al. Role of the Autonomic Nervous System in Atrial Fibrillation: Pathophysiology and Therapy , 2014, Circulation research.
[38] Claude Bouchard,et al. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders , 2014 .
[39] A. Morris,et al. Transethnic Meta-Analysis of Genomewide Association Studies , 2011, Genetic epidemiology.
[40] N. Bursac,et al. Fibroblast Growth Factor Homologous Factor 13 Regulates Na+ Channels and Conduction Velocity in Murine Hearts , 2011, Circulation research.
[41] S. Johnston,et al. Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States , 2011, Circulation. Cardiovascular quality and outcomes.
[42] Sunil K. Agarwal,et al. Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study , 2011, Circulation.
[43] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[44] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[45] Francis S. Collins,et al. Human laminopathies: nuclei gone genetically awry , 2006, Nature Reviews Genetics.
[46] T. Willson,et al. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma. , 2006, Bioorganic & medicinal chemistry letters.
[47] F. Muntoni,et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.
[48] D. Levy,et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.